Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function
Mythili Koneru1, David Schaer, Ngozi Monu
1Department of Cell Biology and Kaplan Cancer Center, New York University School of Medicine, New York, NY 10016, USA.
Abstract:
CD8+ tumor-infiltrating lymphocytes (TIL) are severely deficient in cytolysis, a defect that may permit tumor escape from immune-mediated destruction. Because lytic function is dependent upon TCR signaling, we have tested the hypothesis that primary TIL have defective signaling by analysis of the localization and activation status of TIL proteins important in TCR-mediated signaling. Upon conjugate formation with cognate target cells in vitro, TIL do not recruit granzyme B+ granules, the microtubule-organizing center, F-actin, Wiskott-Aldrich syndrome protein, nor proline rich tyrosine kinase-2 to the target cell contact site. In addition, TIL do not flux calcium nor demonstrate proximal tyrosine kinase activity, deficiencies likely to underlie failure to fully activate the lytic machinery. Confocal microscopy and fluorescence resonance energy transfer analyses demonstrate that TIL are triggered by conjugate formation in that the TCR, p56lck, CD3zeta, LFA-1, lipid rafts, ZAP70, and linker for activation of T cells localize at the TIL:tumor cell contact site, and CD43 and CD45 are excluded. However, proximal TCR signaling is blocked upon conjugate formation because the inhibitory motif of p56lck is rapidly phosphorylated (Y505) and COOH-terminal Src kinase is recruited to the contact site, while Src homology 2 domain-containing protein phosphatase 2 is cytoplasmic. Our data support a novel mechanism explaining how tumor-induced inactivation of proximal TCR signaling regulates lytic function of antitumor T cells.
Insights
Tumor-infiltrating lymphocytes (TIL) fail to kill cancer cells due to defective T-cell receptor (TCR) signaling. Tumor cells inactivate proximal TCR signaling, preventing T cells from activating their killing machinery.
Area of Science:
- Immunology
- Cancer Biology
- T-cell Signaling
Background:
- CD8+ tumor-infiltrating lymphocytes (TIL) are crucial for anti-tumor immunity but often exhibit impaired cytotoxic function.
- This deficiency in cytolysis can allow tumors to evade immune destruction.
- T-cell receptor (TCR) signaling is essential for T-cell mediated killing.
Purpose of the Study:
- To investigate the hypothesis that primary TIL possess defective TCR signaling.
- To analyze the localization and activation status of key proteins involved in TCR-mediated signaling within TIL.
Main Methods:
- In vitro conjugate formation between TIL and cognate target cells.
- Confocal microscopy and fluorescence resonance energy transfer (FRET) analyses.
- Assessment of protein localization, calcium flux, and tyrosine kinase activity.
Main Results:
- TIL failed to recruit essential lytic machinery components (granzyme B, microtubule-organizing center) to the target cell contact site.
- While initial TCR complex components localized correctly, proximal signaling was blocked.
- Tumor cells induced phosphorylation of p56lck inhibitory motif and recruited inhibitory kinases, leading to impaired T-cell activation.
Conclusions:
- Tumor cells employ a mechanism to inactivate proximal TCR signaling in TIL.
- This inactivation disrupts the T-cell's ability to activate its cytotoxic machinery, contributing to tumor immune escape.
- Understanding this pathway offers potential targets for enhancing anti-tumor immunity.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
The Extrinsic Apoptotic Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Tumor Immunotherapy


